I raised this with SI at the penultimate AGM (to rocket launch) and he was circumspect with his statements.
The upshot is we remain focused on proof of those products and treatments which are in the pipeline and will be remunerative.
Longer term such as you mention, surely will be in a queue ...
I've never felt more relieved than at the current rise, for all the right reasons.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Orphan Drug Designation for Revascor
Ann: FDA Grants Orphan Drug Designation for Revascor, page-250
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.05 |
Change
-0.015(1.41%) |
Mkt cap ! $1.198B |
Open | High | Low | Value | Volume |
$1.09 | $1.09 | $1.05 | $4.232M | 3.978M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 61694 | $1.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.06 | 45910 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 61694 | 1.050 |
5 | 205370 | 1.045 |
9 | 131413 | 1.040 |
5 | 191185 | 1.035 |
6 | 60439 | 1.030 |
Price($) | Vol. | No. |
---|---|---|
1.060 | 45910 | 3 |
1.065 | 10650 | 3 |
1.070 | 79000 | 3 |
1.075 | 11047 | 2 |
1.080 | 76190 | 6 |
Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.06 |
  |
Change
-0.015 ( 0.63 %) |
|||
Open | High | Low | Volume | ||
$1.09 | $1.09 | $1.05 | 969435 | ||
Last updated 15.59pm 15/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online